Investment Q&A

Q: Good afternoon,

I’d like to commend 5i on the well thought out updates!

Looking to form a healthcare position. 3-5 positions. Long term growth in a TFSA.
These could be pharmaceutical, equipment etc etc.


Thank you very much.

Q: Is there any recent news on this company? I'm thinking of moving on from my investment.

Q: ISRG has been limping along for the past several months. I am now down 2%. I also note this stock is not owned by any 5i staff. And yet 5i consistently recommends it as one of the solid high growth stocks to invest in for the next 3-5 years. What is it going to take to get the stock moving again...and (gazing into that crystal ball on your desk) how long before momentum shifts and it starts behaving better? Running out of patience here, especially when there are so many stocks out there that are performing better. Thank you.

Q: Dear 5i team.
The following was your response to a bond question I asked in '24.

"Nothing is guaranteed, but bonds' leverage is highly correlated to their maturity. CLF has a relatively low duration of 2.8 years, whereas XLB is 15 years. As a general rule, for every 1% increase or decrease in interest rates, a bond's price will change approximately 1% in the opposite direction for every year of duration. With a bond ETF in theory the move should be similar, and thus XLB in theory should see a much larger move than CLF when rates move (either way). In reality it is not so concrete, and depends on variables in the yield curve and other factors (supply/demand). But we would be very confident in saying that if rates move lower XLB's bond portfolio should do significantly better than CLF. Owning XLB is essentially a 'bet' that rates will drop. As such, we would be fine owning both XBB and XLB for a bit more diversification of bonds. XBB's duration is 7.5 years so a good middle ground between CLF and XLB."

Been watching XLB/XBB for some time now, and both appear to be in downward trends in terms of share price, and close on yields. Rates have been steady, or in decline, so I'm completely confused.
Please take a look and try to make sense of this for me?

Many thanks for your help.

Q: With the latest news release indicating that there is an acquisition that will likely take place some time in the future is there any reason to hold this stock until then to basically get the same $$ as where it is trading now ? I suppose there is always a chance another offer is made at a higher price.

Q: I would like to hear your opinion on investing in silver and uranium. Can you give me 2 or 3 stocks in each sector preferably on thr TSX. Thank you.

Q: Back in May, Craig had asked a question about BRK.B and its current valuation, and the response was:
"Historical multiples have been in the range of 17X to 33X, with an average in the low 20s. It is 25X right now so on the high side of history."

A few questions:
- was this referring to a PE ratio?
- now that it has declined a bit, what is the current valuation multiple?
- is this ratio listed in the BRK.B "profile" page on 5i?

Q: Hi Team,
If adding between these two names (GENI vs SRAD) would you add to one over the other or add to both? Should one "deserve" to be held at a higher weighting?
Thanks

Q: I've set aside $50,000 to pay tax instalments in September and December. can you recommend a fairly safe investment that would provide decent income while I wait?

Q: I would be interested in your opinion on this investment, and the appropriateness of holding in a non-reg account for income with a reasonable level of capital protection for a retiree but not necessarily requiring the income to live on.

Q: Hi, when looking at what sectors your companies fit in, what source do you use and why are there many different sites that give different sectors? For example, Dollarama. I see that you have it as cons cyclical in your portfolio, as well as does Koyfin. But when I look at yahoo, tmx, morning star, and globe and mail, they have it listed as cons staples? Which trusted source should we go with when allocating %'s to our sectors because it could throw off our sector allocations if not allocated properly. Thanks!

Q: Looking for an additional, fresh, minor holding in Consumer sector-- Bath & Body Works.
PE 8, well covers the dividend of 0.80 on $32USD price
Analyst earning forecast positive.
Morningstar Analyst rating 5 star. FV of $61USD.
For comparison: often-covered ULTA is 2 star now.
Thoughts? (any big red flags?)
With thanks.

Q: Gordon Reid recommended Mas Tec this morning on Market Call. Can I have your opinion on the this company please?

Thanks for all your help.

Mike

Q: Hi 5i Team - Could you provide an update on Logan Energy, its fundamentals and balance sheet, insider ownership, expected revenue and cash flow growth. Also could you comment on management which apparently has had success in prior ventures.
Thanks.

Q: Health care as a sector has me puzzled. I was adding to my positions in XLV and IHI during 2023-2024. I was prompted to keep investing thinking demographics would favor growth; that elective medical procedures postponed would come roaring back in the years following Covid. Mostly good companies were held in the above ETFs, and I was comfortable investing also because of familiarity with products and services. Markets have proven me wrong. My cost base is markedly higher than valuations today. XLV is down ~5.25% over the past 12 months (year-to-date return is flat —down -0.05%).IHI, although slightly up ~4.28% YTD, has still not recovered from a 20% drop in 2022. (Losses I show are much greater and are not useable for tax).
Current officials in the US admin have no clue on how to go about drug price reforms. Worse: they don’t know that they have no clue. Reforms are necessary; and PBMs are rightly under scrutiny for opaque pricing practices. I say this notwithstanding that UNH has produced the largest dollar loss I have had in several years.
The science and med professionals who DO know how to implement sensible and substantial changes are fired and replaced by sycophantic, subservient ignorant types. Is it therefore prudent now to sell one or both of XLV and IHI and redeploy cash in other areas? OR, would one be giving up at possibly the exact wrong time? Is now finally the time that patience with XLV and IHI has a greater chance of paying off?

Q: Do you folks have any current info wrt Opendoor??? Was $0.57 a couple months ago, $1.67 currently!! I read they were considering a reverse stock split a few months ago to stay compliant with the exchange, I can't see any updates to see if they did that?? This stock has been appreciating in price gradually, but big moves last 3 trading sessions.

Q: Good afternoon 5i team!

I watched an interview with Tom Lee from Fundstrat Capital regarding how he's been named chairman at BNMR. The company is discribed as the Microstrategy (MSTR) of Etherium. Can you offer your thoughts on the company. I've listened to Lee's commentary for the last few years and he's generally been spot on with respect to S&P performance, tech stock performance, and at the moment, seems fairly accurate with his Bitcoin/crypto call. It has had a wild ride over the past couple of weeks, but if it is, in fact another MSTR, then it might be worth dipping a toe in here.....albeit, a very small toe.(lol)

Q: The latest Q results were excellent and the share price in after hours went into the $130's, yet it has drifted down to the $113 range or almost 15% since late June. How would you rate this stock, do you think it deserves more patience? Thank you. John

Q: What are your thoughts about zero-click search and its eventual impact to Google's bottom line. Personally, I was a HUGE, HUGE user of Google search for more than a decade; however, for the last 12-24 months I (and my spouse) have stopped using it all together, preferring chatbots such as MS-Copilot, ChatGPT and Perplexity. And more recently, I hear that some of the companies that are building these LLM's will also introduce their own browsers. Looking at Google's revenue split by segment, "search" represents 50-60% of their total revenue (albeit less and less every year) but it is still 50-60% of Google's revenue. Any impact to this product line for Google, could have major implications to their revenue stream/bottom line - especially if others abandon Google as I have. You are very bullish on Google, it is trading at lower multiples compared to other Mag7 stocks and am considering an investment. What are your thoughts 3-5-10 years down the road, considering a potential impact on their key revenue stream and/or any other potential risks/benefits you envision. Thank You!

Q: What's driving SHOP up so much the past week or so? I see there was a report on crypto currency payments that seemed quite favourable. Where do you see it going over the next 6 months? From what I see, most analysts have it as a buy but some of the target prices are good but not great.